|
NEWS, EVENTS, and DEADLINES
May 7, 2025
| | Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | | |
Virtual Workshop
Metabolomics in Human Cohort Studies:
From Processing to Associations
presented by
Dr. Ellen Francis and Dr. Randi K. Johnson
| | |
Ellen Francis, Ph.D
Rutgers School of Public Health
| | |
Randi K. Johnson, PhD, MPH
University of Colorado
| | |
May 15
12 - 1:30 PM
Virtual
| | | | |
Princeton Precision Health
2025 Seminar Series
Princeton Precision Health is a cross-cutting initiative that uses AI and data science to transform human health at all levels, from molecular to social to environmental, with the goal of enacting smart policy and evidence-based clinical practice.
| | | Propelus I-Corps is a program designed for research teams with a technology innovation to explore how their discovery can help potential customers and meet industry needs as a startup or venture. | | | | |
June and July 2025
Virtual
| | NJ ACTS Team Science - Get Involved! | | |
NJ ACTS Team Science
Are you the PI or MPI of a funded multidisciplinary, interdisciplinary, or transdisciplinary research project?
The Team Science Core of NJ ACTS hosts a virtual seminar entitled "Team Science Across the NJ ACTS Consortium" that features leaders and team members of multidisciplinary, interdisciplinary, and transdisciplinary research projects taking place within the NJ ACTS consortium to explore how complex research teams are formed, operated, and achieve success.
If you are interested in having your project featured in the series, please let us know by contacting teamscience@rbhs.rutgers.edu.
Participation will allow others to learn from your experiences and will increase the visibility of your project and team.
Watch videos of past seminars on the NJ ACTS Team Science YouTube Playlist
| | |
Princeton Undergraduates Gain Real-World Experience Through Community Health Micro-Internships
Four Princeton undergraduate students — Zoe Tavares, Adrija Kundu, Lena Chau, and Janah Richardson — gave back to communities and gained practical, real-world experience by working with New Jersey-based organizations focused on public health-related projects and research.
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) collaborated with the Program for Community-Engaged Scholarship (ProCES) and community partners to design and fund four different short-term initiatives. These remote projects, which addressed specific community health and organizational needs, offered the Princeton students valuable experiential learning opportunities between the 2024 and 2025 academic semesters. Read the full story from the Princeton Department of Molecular Biology Website.
| | |
Rutgers Faculty Excellence Awards Recipients
NJ ACTS congratulates our members who were among this year's recipients of the Faculty Excellence Awards:
-
Barbara A. Tafuto, Health Informatics, Rutgers Health
-
Pamela A. Ohman Strickland, Biostatistics and Epidemiology, Rutgers Health
-
Stephanie Shiau, Biostatistics and Epidemiology, Rutgers Health
-
Victoria Abraira, Cell Biology and Neuroscience, RU–NB
| | |
The Weill Cornell/Rutgers NeuroHIV Symposium, held on April 24, 2025, marked a pivotal moment in strengthening regional collaboration around HIV and neuroscience research.
| | | | Lishomwa (Lish) Ndhlovu, MD, PhD | | |
Co-led by Tricia Burdo, PhD of Rutgers University and Lishomwa (Lish) Ndhlovu, MD, PhD of Weill Cornell Medicine, the event launched the New York-New Jersey Center for Advancing NeuroHIV Discovery and Innovation (NY-NJ CANDI) Initiative and brought together researchers from both institutions—each contributing two speakers—to showcase interdisciplinary science and spark new interactions across basic, clinical, and translational fields. The symposium catalyzed connections between emerging and established investigators, fostering meaningful networking opportunities and seeding new cross-institutional collaborations that are expected to accelerate progress in neuroHIV research.
With a mission to advance discovery, transform therapies, and ultimately improve outcomes for people with or at risk for HIV, NY-NJ CANDI aims to grow a regional research ecosystem that drives innovation and extends its impact far beyond the bi-state area.
| | |
Rutgers Health-IDEA Grants
The mission of the Rutgers Health-IDEA innovation grants is to fund action-oriented projects that help build an inclusive and cohesive culture across Rutgers Health.
As part of our broader institutional commitment to improving health outcomes for the communities we serve, these grants are designed to empower grassroots initiatives that foster connection, belonging, and community.
Deadline to Apply: May 23, 2025
Funding Begins: August 2025 (for the academic year)
| | NCATS, NIH, and Federal News and Events | |
NIH Postpones Common Forms Requirement
The National Institutes of Health (NIH) announced that it has postponed the implementation of Common Forms, initially scheduled for May 25, 2025, until further notice. NIH applicants and recipients must continue to use the current NIH Biosketch and Other Support format pages for applications, Just-in-Time (JIT), and Research Performance Progress Reports. The health sciences libraries will monitor the NIH for future Guide Notices outlining the new effective date and additional implementation details as they are finalized, and we’ll update our resource guide.
| |
Collaboration Webinars from the
Hear from CTSA TIN experts on trial-related topics to improve your project
| | |
Unlocking the Potential of MyCap for Reproductive Health Research
May 21, 2025
12 - 1 pm
Register
| |  | |
The Informed Consent Guidance Manuals and Best Practices & Strategies for Recruiting Participants in Research Resource Manual
September 17, 2025
12 - 1 pm
Register
| | | |
Apply for the Translational Science Interagency Fellowship Program -NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to train fellows in translational science and regulatory science. Learn More about the Program
| |
NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)
| | | | |
